Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines

Journal of Interferon and Cytokine Research

Volumn 20, Issue 5, 2000, Pages 487-498

  Kim, Jong J ^a,b   Yang, Joo S ^a   Dentchev, Tzvete ^a   Dang, Kesen ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; DNA VACCINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LYMPHOTOXIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MILODISTIM; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; ANTIBODY FORMATION; CHEMOKINES; CYTOKINES; FEMALE; GENE EXPRESSION; IMMUNIZATION; INTERLEUKIN-8; LYMPHOCYTE ACTIVATION; MACROPHAGE INFLAMMATORY PROTEIN-1; MICE; MICE, INBRED BALB C; RANTES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VACCINES, DNA;

ANIMALIA;

EID: 0034081948     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900050023906     Document Type: Article

References (47)

1. 1. ULMER, J.B., DONNELLY, J., PARKER, S.E., RHODES, G.H., FELGNER, P.L., DWARKI, V.L., GROMKOWSKI, S.H., DECK, R., DEVITT, C.M., FRIEDMAN, A., HAWE, L.A., LEANDER, K.R., MARINEZ, D., PERRY, H., SHIVER, J.W., MONTGOMERY, D., and LIU, M.A. (1993). Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749.
2. 2. TASCON, R.E., COLSTON, M.J., RAGNO, S., STAVROPOULOS, E., GREGORY, K., and LOWRIE, D.B. (1996). Vaccination against tuberculosis by DNA injection. Nature Med. 2, 888-892.
3. 3. DAVIS, H.L., MICHEL, M.L., and WHALEN, R.G. (1993). DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2, 1847-1851.
4. 4. WANG, B., UGEN, K.E., SRIKANTAN, V., AGADJANYAN, M.G., DANG, K., REFAELI, Y., SATO, A., BOYER, J., WILLIAMS, W.V., and WEINER, D.B. (1993). Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90, 4156-4160.
5. 5. MacGREGOR, R.R., BOYER, J.D., UGEN, K.E., LACY, K., GLUCKMAN, S., BAGARAZZI, M.L., CHATTERGOON, M., BAINE, Y., HIGGINS, T.J., CICCARELLI, R.B., CONEY, L.R., GINSBERG, R.S., and WEINER, D.B. (1998). First human trial of a facilitated DNA plasmid vaccine for HIV-1: safety and host response. J. Infect. Dis. 178, 92-100.
6. 6. WANG, R., DOOLAN, D.L., LE, T.P., HEDSTROM, R.C., COONAN, K.M., CHAROENVIT, Y., JONES, T.R., HOBART, P., MARGALITH, M., NG, J., WEISS, W.R., SEDEGAH, M., DE TAISNE, C., NORMAN, J.A., and HOFFMAN, S.L. (1998). Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282, 476-480.
7. 7. ZIANG, Z., and ERTL, H.C. (1995). Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2, 129-135.
8. 8. IWASAKI, A., STIERNHOLM, B.J., CHAN, A.K., BERSTEIN, N.L., and BARBER, B.H. (1997). Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J. Immunol. 158, 4591-4601.
9. 9. TSUJI, T., HAMAJIMA, K., ISHII, N., AOKI, I., FUKUSHIMA, J., XIN, K.Q., KAWAMOTO, S., SASAKI, S., MATSUNAGA, K., ISHIGATSUBO, Y., TANI, K., OKUBO, T., and OKUDA, K. (1997). Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur. J. Immunol. 27, 782-787.
10. 10. KIM, J.J., BAGARAZZI, M.L., TRIVEDI, N., HU, Y., CHATTERGOON, M.A., DANG, K., MAHALINGAM, S., AGADJANYAN, M.G., BOYER, J.D., WANG, B., and WEINER, D.B. (1997). Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nature Biotech. 15, 641-645.
11. 11. KIM, J.J., AYYVOO, V., BAGARAZZI, M.L., CHATTERGOON, M.A., DANG, K., WANG, B., BOYER, J.D., and WEINER, D.B. (1997). In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158, 816-826.
12. 12. KIM, J.J., TRIVEDI, N.N., NOTTINGHAM, L., MORRISON, L., TSAI, A., HU, Y., MAHALINGAM, S., DANG, K., AHN, L., DOYLE, N.K., WILSON, D.M., CHATTERGOON, M.A., CHALIAN, A.A., BOYER, J.D., AGADJANYAN, M.G., and WEINER, D.B. (1998). Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens. Eur. J. Immunol. 28, 1089-1103.
13. 13. BAGGIOLINI, M., BEATRICE, D., and MOSER, B. (1997). Human chemokines: an update. Annu. Rev. Immunol. 15, 675-705.
14. 14. SCHALL, T.J., and BACON, K.B. (1994). Chemokines, leukocyte trafficking, and inflammation. Curr. Opin. Immunol. 6, 865-873.
15. 15. BLEUL, C.C., FARZAN, M., CHOE, H., PAROLIN, C., CLARK-LEWIS, I., SODROSKI, J., and SPRINGER, T.A. (1996). The lymphocyte chemoattractant SSDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 382, 829-832.
16. 16. OBERLIN, E., AMARA, A., BACHELERIE, F., BESSIA, C., VIRELIZIER, J.-L., ARENZANA-SEISDEDOS, F., SCHWARTZ, O., HEARD, J.-M., CLARK-LEWIS, I., LEGLER, D.F., LOETSCHER, M., BAGGIOLINI, M., and MOSER, B. (1996). The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 382, 833-835.
17. + T cells. Science 270, 1811-1815.
18. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
19. 19. DENG, H.K., LIU, R., ELLEMEIER, W., CHOE, S., UNUTMAZ, D., BURKHART, M., DI MARZIO, P., MARMON, S., SUTTON, R.E., HILL, C.M., DAVIS, C.B., PEIPER, S.C., SCHALL, T.J., LITTMAN, D.R., and LANDAU, N.R. (1996). Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
20. 20. CHOE, H., FARZAN, M., SUN, Y., SULLIVAN, N., ROLLINS, B., PONATH, P.D., WU, L., MACKAY, C.R., LAROSA, G., NEWMAN, W., GERARD, N., GERARD, C., and SODROSKI, J. (1996). The b-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85, 1135-1148.
21. 21. DORANZ, B.J., RUCKER, J., YI, Y., SMYTH, R.J., SAMSON, M., PEIPER, S.C., PARMENTIER, M., COLLMAN, R.G., and DOMS, R.W. (1996). A dual-tropic primary HIV-1 isolate that uses fusin and the b-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85, 1149-1158.
22. 22. ALKHATIB, G., COMBADIERE, C., BODER, C.C., FENG, Y., KENNEDY, P.E., MURPHY, P.M., and BERGER, E.A. (1996). CC CKR5: A RANTES, MIP-1a, MIP-1b receptor as a fusion co-factor for macrophage-tropic HIV-1. Science 272, 1955-1958.
23. 23. WARD, S.G., BACON, K., and WESTWICK, J. (1998). Chemokines and T lymphocytes: more that an attraction. Immunity 9, 1-11.
24. 24. KIM, J.J., NOTTINGHAM, L.K., SIN, J.I., TSAI, A., MORRISON, L., OH, J., DANG, K., HU, Y., KAZAHAYA, K., BENNETT, M., DENTCHEV, T., WILSON, D.M., CHALIAN, A.A., BOYER, J.D., AGADJANYAN, M.G., and WEINER, D.B. (1998). CD8 positive T cells control antigen-specific immune responses through the expression of chemokines. J. Clin. Invest. 102, 1112-1124.
25. 25. CALLARD, R., and GEARING, A. (1994). The Cytokine Facts Book. London: Academic Press.
26. 26. KIM, J.J., MAGUIRE, H.C., JR., NOTTINGHAM, L.K., MORRISON, L.D., TSAI, A., SIN, J.I., CHALIAN, A.A., and WEINER, D.B. (1998). Co-administration of IL-12 or IL-10 expression cassettes drives immune responses toward a Th1 phenotype. J. Interferon Cytokine Res. 18, 537-547.
27. 27. MOGENSEN, S.C., and VIRELIZIER, J.L. (1987). The interferon-macrophage alliance [Review]. Interferon 8, 55-84.
28. + T cells. Annu. Rev. Immunol. 12, 635-673.
29. 29. DOE, B., SELBY, M., BARNETT, S., BAENZINGER, J., and WALKER, C.M. (1996). Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc. Natl. Acad. Sci. USA 93, 8578-8583.
30. 30. CORR, M., LEE, D.J., CARSON, D.A., and TIGHE, H. (1996). Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555-1560.
31. 31. CASARES, S., INABA, K., BRUMEANU, T.D., STEINMAN, R.M., and BONA, C.A. (1997). Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J. Exp. Med. 186, 1481-1486.
32. 32. CHATTERGOON, M.A., ROBINSON, T.A., BOYER, J.D., and WEINER, D.B. (1998). Specific immune induction following DNA-based immunization through in vivo transfection and activation of macrophages. J. Immunol. 160, 5707-5718.
33. 33. KIM, J.J., and WEINER, D.B. (1997). DNA/genetic vaccination for HIV. Springer Semin. Immunopathol. 19, 174-195.
34. 34. MURPHY, P.M. (1994). The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12, 593-633.
35. 35. MOORE, M.A. (1991). The clinical use of colony-stimulating factors. Annu. Rev. Immunol. 9, 159-191.
36. 36. KOBAYASHI, M., FITZ, L., RYAN, M., HEWICK, R.M., CLARK, S.C., CHAN, S., LOUDON, R., SHERMAN, F., PERUSSIA, B., and TRINCHIERI, G. (1989). Identification and purification of natural killer cell stimulator factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 10, 827-845.
37. 37. GATELY, M.K., WOLITZKY, A.G., QUINN, P.M., and CHIZZONITE, R. (1992). Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell. Immunol. 143, 127-142.
38. 38. ROBERTSON, M.J., SOIFFER, R.J., WOLF, S.F., MANLEY, T.J., DONAHUE, C., YOUNG, D., HERMANN, S.H., and RITZ, J. (1992). Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175, 779-788.
39. 39. SKERKA, C., IRVING, S.G., BIALONSKI, A., and ZIPFEL, P.F. (1993). Cell type-specific expression of members of the IL-8/NAP-1 gene family. Cytokine 5, 112-116.
40. 40. WECHSLER, A.S., GORDON, M.C., DENDORFER, U., and LECLAIR, K.P. (1994). Induction of IL-8 expression in T cells uses the CD28 costimulatory pathway. J. Immunol. 153, 2515-2123.
41. 41. TAUB, D.D., LLOYD, A.R., CONLON, K., WANG, J.M., ORTALDO, J.R., HARADA, A., MATSUSHIMA, K., KELVIN, D.J., and OPPENHEIM, J.J. (1993). Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med. 177, 1809-1814.
42. 42. ROT, A., KRIEGER, M., BRUNNER, T., BISCHOFF, S.C., SCHALL, T.J., and DAHINDEN, C. (1992). RANTES and macrophage inflammatory protein 1 alpha induce the migration and activation of normal human eosinophil granulocytes. J. Exp. Med. 176, 1489-1495.
43. 43. ALAM, R., FORSYTHE, P.A., STAFFORD, S., LETT-BROWN, M.A., and GRANT, J.A. (1992). Macrophage inflammatory protein-1 alpha activates basophils and mast cells. J. Exp. Med. 176, 781-786.
44. 44. SCHALL, T.J., BACON, K., CAMP, R.D., KASPARI, J.W., and GOEDDEL, D.V. (1993). Human macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta chemokines attract distinct populations of lymphocytes. J. Exp. Med. 177, 1821-1826.
45. 45. SCHALL, T.J., BACON, K., TOY, K.J., and GOEDDEL, D.V. (1990). Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347, 669-671.
46. 46. MURPHY, W.J., TAUB, D.D., ANVER, M., CONLON, K., OPPENHEIM, J.J., KELVIN, D.J., and LONGO, D.L. (1994). Human RANTES induces the migration of human T lymphocytes into the peripheral tissues of mice with severe combined immune deficiency. Eur. J. Immunol. 24, 1823-1827.
47. 47. MEURER, R., VAN RIPER, G., FEENEY, W., CUNNINGHAM, P., HORA, D., JR., SPRINGER, M.S., MACINTYRE, D.E., and ROSEN, H. (1993). Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8. J. Exp. Med. 178, 1913-1921.